PERCEPTIVE ADVISORS LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001224962

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2024 · 109 positions · Total reported value $4.10B · Top-10 concentration 47.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.5% · 26 new · 28 cut · 12 exited

Active Share (vs S&P 500): 98.8% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +23.3% · vs SPY +8.4% · Prev Value $4.76B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2024 13F filing, PERCEPTIVE ADVISORS LLC disclosed 109 equity positions with a combined reported value of $4.10B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 47.8% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were CERE ($441.40M), FOLD ($278.33M), ACLX ($214.67M). By sector, the heaviest allocations are Health Care 52.4%, Industrials 0.9%. Versus the prior quarter, allocation shifted toward Other (+2.7pp) and away from Health Care (-2.9pp).

Versus the prior quarter, PERCEPTIVE ADVISORS LLC opened 26 new positions, trimmed 28 and fully exited 12, a turnover rate of 55.5% of positions. The portfolio's overlap with the prior quarter was 71% of names.

The largest new positions opened in Q2 2024 were CTNM ($27.59M), MRUS ($17.75M), RAPP ($17.40M).

Of the 12 positions fully exited versus the prior quarter, the largest were FUSN ($145.52M), SRPT ($68.05M), LABP ($31.94M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • CTNM CONTINEUM THERAPEUTICS INC CL A · $27.59M
  • MRUS MERUS N V · $17.75M
  • RAPP RAPPORT THERAPEUTICS INC · $17.40M
  • CGEM CULLINAN THERAPEUTICS INC · $13.08M
  • INSM INSMED INC · $12.06M
  • BCYC BICYCLE THERAPEUTICS PLC · $11.58M
  • ICLR ICON PUB LTD CO · $9.80M
  • TEM TEMPUS AI INC · $9.62M

Fully Exited (vs previous quarter)

  • FUSN FUSION PHARMACEUTICALS INC · prev qtr: $145.52M
  • SRPT SAREPTA THERAPEUTICS INC · prev qtr: $68.05M
  • LABP LANDOS BIOPHARMA INC · prev qtr: $31.94M
  • TMCI TREACE MED CONCEPTS INC · prev qtr: $30.08M
  • AUTL AUTOLUS THERAPEUTICS LTD · prev qtr: $27.63M
  • RVMD REVOLUTION MEDICINES INC · prev qtr: $19.95M · history
  • ABBV ABBVIE INC · prev qtr: $19.39M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · prev qtr: $17.03M

Insider Transactions (Form 4)

Latest PERCEPTIVE ADVISORS LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-26 Opt exercise LeonaBio, Inc. 776,648 $0.00 SEC filing
2026-08-26 Buy Immatics N.V. 863,060 $8.69 SEC filing
2026-07-20 Award Freenome, Inc. 5,500,000 $10.00 SEC filing
2026-06-17 Award Kardigan, Inc. 20,706 — SEC filing
2026-04-17 Award MeiraGTx Holdings plc 555,555 $9.00 SEC filing

All insider transactions →

Fund Profile

Perceptive Advisors is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 107 US equity positions with a combined value of $6.30B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-71841 (status: Approved), registered 2010-10-04
  • Regulatory AUM (Form ADV): $11.77B as of 2026-07-13
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 17 private funds, of which 6 hedge funds

Portfolio Structure

  • 107 positions · $6.30B reported value (Q2 2026)
  • Top 10 holdings = 47.5% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 10.8%
  • Average position size: $58.91M

Sector Tilt

  • Health Care 89.0%
  • Industrials 1.2%
  • Financials 0.1%
  • (classified holdings cover 90% of value)

Quarterly Activity

  • Q2 2026: 26 new, 28 added, 28 reduced, 12 exited
  • 25 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 52.4%
Technology 0.2%
Other 46.5%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 10.79M $441.40M 10.76%
10.76%
Hold
2 28.06M $278.33M 6.79%
6.79%
Hold
3 3.89M $214.67M 5.24%
5.24%
Reduce
4 25.93M $207.98M 5.07%
5.07%
Add
5 2.55M $193.37M 4.71%
4.71%
Reduce
6 3.45M $141.52M 3.45%
3.45%
Add
7 1.86M $140.65M 3.43%
3.43%
Reduce
8 3.20M $130.76M 3.19%
3.19%
Add
9 1.72M $117.56M 2.87%
2.87%
Add
10 8.09M $93.96M 2.29%
2.29%
Add
11 649.91K $89.47M 2.18%
2.18%
Reduce
12 2.11M $82.86M 2.02%
2.02%
Add
13 264.60K $74.13M 1.81%
1.81%
Reduce
14 2.79M $71.66M 1.75%
1.75%
Add
15 3.03M $71.26M 1.74%
1.74%
Add
16 1.48M $66.12M 1.61%
1.61%
Hold
17 5.75M $62.43M 1.52%
1.52%
Hold
18 1.65M $62.27M 1.52%
1.52%
Reduce
19 3.68M $60.47M 1.48%
1.48%
Add
20 6.49M $59.02M 1.44%
1.44%
Hold
21 530.00K $57.39M 1.40%
1.40%
Reduce
22 7.10M $51.75M 1.26%
1.26%
Hold
23 1.49M $51.55M 1.26%
1.26%
Reduce
24 11.33M $47.67M 1.16%
1.16%
Hold
25 1.27M $43.96M 1.07%
1.07%
Add
26 6.91M $39.16M 0.95%
0.95%
Hold
27 2.36M $38.69M 0.94%
0.94%
Hold
28 490.67K $38.62M 0.94%
0.94%
Reduce
29 721.38K $38.24M 0.93%
0.93%
Reduce
30 8.01M $37.38M 0.91%
0.91%
Add
31 459.11K $36.96M 0.90%
0.90%
Reduce
32 3.93M $35.52M 0.87%
0.87%
Add
33 1.30M $35.24M 0.86%
0.86%
Hold
34 2.43M $35.19M 0.86%
0.86%
Reduce
35 1.50M $35.19M 0.86%
0.86%
Add
36 1.86M $33.43M 0.81%
0.81%
Reduce
37 5.36M $31.09M 0.76%
0.76%
Add
38 750.23K $31.03M 0.76%
0.76%
Reduce
39 2.77M $30.98M 0.76%
0.76%
Reduce
40 1.22M $30.78M 0.75%
0.75%
Reduce
41 9.28M $30.70M 0.75%
0.75%
Add
42 12.59M $29.47M 0.72%
0.72%
Hold
43 1.57M $27.59M 0.67%
0.67%
New
44 61.80K $27.49M 0.67%
0.67%
Reduce
45 1.03M $27.36M 0.67%
0.67%
Reduce
46 1.25M $26.84M 0.65%
0.65%
Reduce
47 553.44K $24.94M 0.61%
0.61%
Add
48 444.00K $24.34M 0.59%
0.59%
Add
49 733.70K $23.16M 0.56%
0.56%
Reduce
50 583.26K $22.74M 0.56%
0.56%
Reduce

FAQ

What did PERCEPTIVE ADVISORS LLC buy in 2024-Q2?

In its 2024-Q2 13F filing, PERCEPTIVE ADVISORS LLC reported 109 equity positions worth $4.10B in aggregate; its largest disclosed positions were CERE ($441.40M), FOLD ($278.33M), ACLX ($214.67M).

How large is PERCEPTIVE ADVISORS LLC's portfolio?

PERCEPTIVE ADVISORS LLC reported $4.10B of long equity holdings across 109 positions as of 2024-Q2. Top-10 holdings account for 47.8% of reported value.

What is PERCEPTIVE ADVISORS LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/perceptive-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →